Jaguar Health (JAGX) Share-based Compensation (2014 - 2026)

Jaguar Health's (JAGX) quarterly Share-based Compensation came in at $452.0 million in Q1 2026, up 132451.32% year-on-year from N/an in Q1 2025, and up 92144.9% on a QoQ basis from $490000.0 in Q4 2025.

Jaguar Health (JAGX) Share-based Compensation (2014 - 2026) Analysis & Trends

Jaguar Health (JAGX) has 13 years of Share-based Compensation data on file, last reported at $452.0 million in Q1 2026.

  • On a quarterly basis, Share-based Compensation rose 132451.32% year-over-year to $452.0 million in Q1 2026; TTM through Mar 2026 was $452.0 million, a 18303.91% increase from a year earlier, with the FY2025 full-year figure at $569.0 million, down 99.92% from the prior year.
  • Share-based Compensation for Q1 2026 stood at $452.0 million, up from $490000.0 in the prior quarter.
  • Over the last five years, Share-based Compensation for JAGX reached as high as $452.0 million in Q1 2026 and fell as low as $90000.0 in Q1 2022.
  • Historically, Share-based Compensation has averaged $52.3 million across 5 years, with a median of $490000.0 in 2025.
  • Across the five-year window, Share-based Compensation tumbled 87.57% in 2022 and surged 138287.1% in 2025, its largest moves.
  • Year by year, Share-based Compensation stood at $142000.0 in 2022, then soared by 306.34% to $577000.0 in 2023, then jumped by 146.45% to $1.4 million in 2024, then slumped by 65.54% to $490000.0 in 2025, then jumped by 92144.9% to $452.0 million in 2026.
  • Per Business Quant data, the three most recent Share-based Compensation figures were $452.0 million in Q1 2026, $490000.0 in Q4 2025, and $429.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Nanobiotix 1,782.24 Bn 1,782.18 Bn - -
2 Akari Therapeutics 1,009.43 Bn 1,009.43 Bn - 305,000.00
3 BeOne Medicines 473.46 Bn 468.66 Bn 1.35 Bn 9.26 Mn
4 Vertex Pharmaceuticals 123.84 Bn 116.59 Bn 2.59 Bn 166.40 Mn
5 Regeneron Pharmaceuticals 71.69 Bn 62.94 Bn 3.31 Bn 257.40 Mn
6 Belite Bio 62.15 Bn 62.15 Bn - -
7 Argenx Se 54.74 Bn 49.55 Bn 1.41 Bn -
8 Alnylam Pharmaceuticals 38.08 Bn 35.07 Bn 959.66 Mn -
9 Revolution Medicines 36.07 Bn 36.07 Bn - 87.30 Mn
10 Jaguar Health 520,945.88 -9.54 Mn 19.11 Mn 452.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 452.00 Mn
Mar 31, 2026 452.00 Mn
Dec 31, 2025 490,000.00
Dec 31, 2025 490,000.00
Sep 30, 2025 429.00 Mn
Sep 30, 2025 429.00 Mn
Jun 30, 2025 279,000.00
Jun 30, 2025 279,000.00
Mar 31, 2025 341,000.00
Mar 31, 2025 341,000.00
Dec 31, 2024 1.42 Mn
Dec 31, 2024 1.42 Mn
Sep 30, 2024 310,000.00
Sep 30, 2024 310,000.00
Jun 30, 2024 383,000.00
Jun 30, 2024 383,000.00
Mar 31, 2024 221,000.00
Mar 31, 2024 221,000.00
Dec 31, 2023 577,000.00
Dec 31, 2023 577,000.00